Gavin Painter
GavinPainter,ProfessorofVictoriaUniversityofWellington,LowerHutt,NewZealand.ProfessorGavinPainterisdevelopingnewtreatmentsforcancerthatharnessthebody’sownimmunesystemtofightthedisease.ThiscancerimmunotherapyworkispartofanongoingcollaborationwithimmunologistsattheMalaghanInstituteofMedicalResearch.Unlikechemotherapeuticagentsthattargetmalignanttissuedirectly,cancervaccinestargettheimmunesystem.Theyarewelltoleratedbythebodyandhavefewersideeffectsthantraditionaltreatments.“Thevaccineskick-starttheimmunesystem,whichsendsitsowncellstokillthemalignanttissue.“Toincreasevaccinespecificityandpotencyweareusingleadingedgeconjugationandlinkerstrategiestomakenewclassesofsyntheticvaccinesthattargetthevaccinecomponentstospecialisedimmunecells.”Gavincollaborateswithsyntheticchemists,pharmacologists,immunologistsandcliniciansfromOtago,VictoriaandAucklanduniversitiesandCapital&CoastDistrictHealthBoard.HelooksforwardtoseeingtheNewZealand-basedresearchcommercialisedinthiscountry.
Gavin Painter, Professor of Victoria University of Wellington, Lower Hutt, New Zealand. Professor Gavin Painter is developing new treatments for cancer that harness the body’s own immune system to fight the disease. This cancer immunotherapy work is part of an ongoing collaboration with immunologists at the Malaghan Institute of Medical Research.Unlike chemotherapeutic agents that target malignant tissue directly, cancer vaccines target the immune system. They are well tolerated by the body and have fewer side effects than traditional treatments.“The vaccines kick-start the immune system, which sends its own cells to kill the malignant tissue. “To increase vaccine specificity and potency we are using leading edge conjugation and linker strategies to make new classes of synthetic vaccines that target the vaccine components to specialised immune cells.”Gavin collaborates with synthetic chemists, pharmacologists, immunologists and clinicians from Otago, Victoria and Auckland universities and Capital & Coast District Health Board. He looks forward to seeing the New Zealand-based research commercialised in this country.
欢迎访问东方智库

会员登录 | 免费注册

讲师入驻通道

免费咨询热线:13810808675

热门搜索:部委学者  |  经济学家  |  培训课程  |  周延礼  |  蒋昌建  |  
首页 > 知名专家 > 医疗健康专家 > 查看详情
Gavin Painter
Gavin Painter  GavinPainter,ProfessorofVictoriaUniversityofWellington,LowerHutt,NewZealand.ProfessorGavinPainterisdevelopingnewtreatmentsforcancerthatharnessthebody’sownimmunesystemtofightthedisease.ThiscancerimmunotherapyworkispartofanongoingcollaborationwithimmunologistsattheMalaghanInstituteofMedicalResearch.Unlikechemotherapeuticagentsthattargetmalignanttissuedirectly,cancervaccinestargettheimmunesystem.Theyarewelltoleratedbythebodyandhavefewersideeffectsthantraditionaltreatments.“Thevaccineskick-starttheimmunesystem,whichsendsitsowncellstokillthemalignanttissue.“Toincreasevaccinespecificityandpotencyweareusingleadingedgeconjugationandlinkerstrategiestomakenewclassesofsyntheticvaccinesthattargetthevaccinecomponentstospecialisedimmunecells.”Gavincollaborateswithsyntheticchemists,pharmacologists,immunologistsandcliniciansfromOtago,VictoriaandAucklanduniversitiesandCapital&CoastDistrictHealthBoard.HelooksforwardtoseeingtheNewZealand-basedresearchcommercialisedinthiscountry.
GavinPainter,ProfessorofVictoriaUniversityofWellington,LowerHutt,NewZealand.ProfessorGavinPainterisdevelopingnewtreatmentsforcancerthatharnessthebody’sownimmunesystemtofightthedisease.Thiscancerimmuno...
  • 联系方式:
  • 手机号码:
  • 联系邮箱:
  • 微信扫码联系

    微信咨询

邀请费用:面议

邀请讲课
官方电话:13810808675
http://www.zgdfzk.com/index.php/ylyx/71645.html
详细介绍
Gavin Painter, Professor of Victoria University of Wellington, Lower Hutt, New Zealand. Professor Gavin Painter is developing new treatments for cancer that harness the body’s own immune system to fight the disease. This cancer immunotherapy work is part of an ongoing collaboration with immunologists at the Malaghan Institute of Medical Research.Unlike chemotherapeutic agents that target malignant tissue directly, cancer vaccines target the immune system. They are well tolerated by the body and have fewer side effects than traditional treatments.“The vaccines kick-start the immune system, which sends its own cells to kill the malignant tissue. “To increase vaccine specificity and potency we are using leading edge conjugation and linker strategies to make new classes of synthetic vaccines that target the vaccine components to specialised immune cells.”Gavin collaborates with synthetic chemists, pharmacologists, immunologists and clinicians from Otago, Victoria and Auckland universities and Capital & Coast District Health Board. He looks forward to seeing the New Zealand-based research commercialised in this country.

上一篇:王广科

下一篇:Rod Dunbar

快速发布需求
重新获取验证码

推荐讲师

专家动态

联系我们
微信咨询
微信咨询
微信扫一扫